Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 0 · FY2022 0 · FY2023 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2023 annual report, the company provides health services. Founded 24 February 2005.
| Ratio | 2021 | 2022 | 2023 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 23.1% | 38.8% | 33.4% |
| EBITDA Margin | -16.5% | 4.6% | 2.7% |
| EBITDAR | -137 | 146 | 134 |
| EBITDAR Margin | -10.7% | 10.4% | 9.6% |
| EBIT Margin | -18.1% | 2.8% | 0.9% |
| Net Profit Margin | 6.1% | 8.9% | -9.2% |
| Operating Expense % of Sales | 39.6% | 34.2% | 38.4% |
| Returns | |||
| Return on Assets (ROA) | 6.2% | 7.0% | -6.5% |
| Return on Equity (ROE) | N/A | 1372.7% | N/A |
| ROIC [EBIT / Invested Capital] | -35.1% | 4.0% | 1.1% |
| Leverage & debt balances | |||
| Debt-to-Assets | 68.6% | 70.7% | 76.9% |
| Debt-to-Equity | -7.51x | 139.45x | -12.44x |
| Debt-to-EBITDA | N/A | 19.53x | 39.93x |
| Equity-to-Assets | -9.1% | 0.5% | -6.2% |
| Net Debt | 780 | 993 | 1,303 |
| Cash & Equivalents | 88 | 274 | 209 |
| Total Debt | 868 | 1,267 | 1,512 |
| Liquidity & working capital | |||
| Current Ratio | 0.83x | 1.11x | 0.99x |
| Quick Ratio | 0.78x | 1.07x | 0.96x |
| Cash Ratio | 0.15x | 0.47x | 0.32x |
| Total Current Assets | 498 | 652 | 652 |
| Total Current Liabilities | 597 | 586 | 659 |
| Inventory | 30 | 24 | 23 |
| Trade Receivables | 284 | 301 | 337 |
| Trade Payables | 220 | 213 | 271 |
| Net Working Capital | -99 | 67 | -6 |
| Net Working Capital % of Revenue | -7.7% | 4.8% | -0.5% |
| Trade Working Capital | 94 | 111 | 89 |
| Trade Working Capital % of Revenue | 7.3% | 7.9% | 6.4% |
| Change in Trade Working Capital | N/A | 17 | -22 |
| Turnover & efficiency | |||
| Inventory Turnover | 32.67x | 36.38x | 40.45x |
| Days Inventory Outstanding (DIO) | 11.2 | 10.0 | 9.0 |
| Receivables Turnover | 4.54x | 4.67x | 4.13x |
| Days Sales Outstanding (DSO) | 80.4 | 78.2 | 88.3 |
| Payables Turnover | 4.50x | 4.03x | 3.42x |
| Days Payable Outstanding (DPO) | 81.1 | 90.5 | 106.6 |
| Cash Conversion Cycle | 10.5 days | -2.2 days | -9.3 days |
| Asset Turnover | 1.02x | 0.78x | 0.71x |
| Cash flow & dividends | |||
| Operating Cash Flow | 100 | 177 | 19 |
| Free Cash Flow (OCF − Capex proxy) | -579 | -251 | 208 |
| Cash Conversion (OCF / EBITDA) | N/A | 273.0% | 48.9% |
| Dividends Declared | 0 | 0 | 0 |
| Dividend Payout Ratio | 0.0% | 0.0% | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →